OpenEvidence筹集2.5亿美元，为医生构建医疗超级智能

OpenEvidence, the most widely-used AI platform by doctors in America, announced today that it closed a Series D round of funding, raising $250 million and valuing the company at $12 billion, making it the most valuable healthcare AI company in the world. OpenEvidence is a specialized AI-powered medical search engine designed to provide doctors with quick and accurate medical information retrieval and decision support. The platform leverages natural language processing (NLP) and machine learning (ML) technologies to extract key information from vast medical literature and clinical data, aiding doctors in making more informed decisions during diagnosis and treatment. The funding will be used to further develop its medical superintelligence system, which will integrate more advanced AI technologies such as deep learning (DL) and large language models (LLMs) to enhance the platform's intelligence and practicality. The successful funding and valuation growth of OpenEvidence not only highlight its leading position in the medical AI field but also reflect the market's immense confidence and anticipation for AI applications in healthcare. In the future, OpenEvidence plans to expand its service coverage to more medical specialties and regions, providing comprehensive intelligent support to doctors worldwide.